FBIO $2 cancer drug approval soon ..market cap $18 million which is a big joke ...another 3 NDA/BLA filings expected within 12 months
Biologics License Application for cosibelimab under review by U.S. FDA; Successful mid-cycle meeting with U.S. FDA completed; PDUFA goal date of January 3, 2024
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.